• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Product News

Products News

Spectral CT scanner

, 26 August 2020/in Product News /by 3wmedia

Representing an evolution of the original detector-based IQon Spectral CT scanner, the IQon Elite advances the capabilities of its predecessor through a series of key benefits that support emergency/trauma department care and oncology care. This new configuration provides a number of enhanced features, including faster reconstruction speeds and better visualization of bone marrow pathology which increases diagnostic confidence within emergency and trauma departments, providing the opportunity to reduce the need for subsequent scans. The system’s ability to estimate electron density provides enhanced tissue characterization. IQon Elite’s faster reconstruction speeds have been shown to enable up to 200 CT patients per day. This is an important benchmark for healthcare facilities experiencing a high volume of patients, especially in the emergency department where CT can be a commonly-used imaging modality.  The system’s new radiation therapy planning couch and bariatric table top allow larger patients to be scanned with increased positioning controls, providing greater clinical breadth.


Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH249_Philips-scaled.jpg 1676 2560 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:40Spectral CT scanner

Xenios sees growing demand for ECMO devices

, 26 August 2020/in Corona News, Product News /by 3wmedia

Xenios AG, a company of the Fresenius Medical Care Group, reports that it has seen a significant growth in demand for its extracorporeal membrane oxygenation (ECMO) devices, which can be used for the treatment of patients who develop severe pneumonia and acute respiratory distress syndrome (ARDS) due to COVID-19 infection.
Jürgen Böhm, CMO of Xenios, explained that for critically ill COVID-19 patients with acute lung failure and refractory hypoxemia – despite use of standard therapy – “our treatment often remains the last therapeutic option and has been a lifesaver for many patients”.
Xenios’s ECMO therapy bypasses the function of the lungs. The patient’s blood is freed from carbon dioxide outside the body and enriched with oxygen. The lungs are thus given time to heal. Because of the increase of critically ill COVID-19 patients, more physicians are opting for ECMO therapy, and thus the increase in demand for Xenios’s ECMO devices.
To meet the demand, the company has increased production of its ECMO devices. “We have put many measures in place to maximize the utilization of our capacity to manufacture ECMO devices as well as patient kits. Our biggest challenge right now is the availability of specific components for our products,” said Andreas Terpin, CEO of Xenios.
For more information, visit: www.xenios-ag.com
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/PRODUCT_XENIOS.jpg 749 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:17Xenios sees growing demand for ECMO devices

Radiation meter for variety of applications

, 26 August 2020/in Product News /by 3wmedia

Radiation measurement often requires different devices for varying applications adding to the cost and complexity of data collection. The new RaySafe 452 Survey Meter is a versatile, powerful tool that can be used for multiple situations, reducing the number of devices technicians need to carry, learn, and calibrate. The 452 Survey Meter is the ideal tool to measure radiation in a wide variety of applications, including wall leakage, scatted radiation in a room, tube leakage, nuclear medicine, and control of treated patients. The meter helps technicians make data collection accurately and easily with fast response times and detect variations from background radiation levels due to its high sensitivity. There is no need for post processing of the data due to a flat, wide energy response range. With the automatic saving of dose rate values every second data is easily saved to be analysed later. The RaySafe 452 features an optimized modern design that provides a big, clear, easy-to-read display with all the parameters in a single backlit display. Its ergonomic and lightweight design makes it easy to hold, carry, and use even over extended periods of time. And it has an IP 64 rating so it can easily be cleaned with water without damaging the device. The survey meter comes with RaySafe View software that makes it easy to transfer data to a PC and log data quickly, easily, and efficiently. All data is time stamped and dose rate waveforms can be further analysed later.
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH274_Fluke_Biomed_RaySafe_452.jpg 533 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:25Radiation meter for variety of applications

Cardiovascular MRI scanner

, 26 August 2020/in Product News /by 3wmedia

The Magnetom Sola Cardiovascular Edition is a 1.5 Tesla magnetic resonance imaging (MRI) scanner designed specifically for cardiovascular examinations.
Magnetom Sola Cardiovascular Edition incorporates the latest technologies with the specific aim of providing the maximum diagnostic information in cardiovascular examinations. This leads to faster, more reliable, and definitive diagnoses for a larger number of patients with underlying ischemic, structural, and arrhythmogenic conditions.
The MRI scanner’s innovative applications can cut examination times down to 20 minutes and clarify a broad range of clinical questions in cardiology. Guidelines issued by the European Society of Cardiology (ESC) have long described magnetic resonance imaging as the gold standard for assessing the morphology and function of the heart. Over 25 ESC Guidelines now contain specific recommendations describing instances where MRI should be used in cardiac diagnosis. This is primarily due to the accuracy of MRI when quantifying cardiac volume, mass, and wall motion, as well as its ability to diagnose ischemia and myocardial viability. There are also diseases such as myocarditis (inflammation of the heart muscle), for which cardiovascular MRI is the only non-invasive diagnostic option with the pre-requisite sensitivity. By receiving the right diagnosis at the right time, this group of patients can avoid unnecessary invasive procedures.
The Compressed Sensing Cardiac Cine application accelerates MRI scanning sequences so that cardiac function can be measured while the patient is breathing freely. Previous scanners required patients to hold their breath for up to 20 seconds several times during the process. This means that the benefits of the gold standard are now available to new groups of patients, including individuals with arrhythmia or dyspnea who were previously not eligible for CMR. The MyoMaps application provides quantitative information on the tissue composition of the cardiac muscle. This can be used to diagnose diseases of the heart muscle, scar tissue and edema at a very early stage of the condition, allowing the right treatment option to be chosen for the patient as soon as possible. Clinical conditions such as myocarditis can even be detected without using contrast agents. Cardiac Dot Engine is a unique software package which provides step-by-step guidance for standardized diagnostic cardiac MRI exams. It is based on artificial intelligence algorithms, allows users to navigate confidently through the cardiovascular MRI scanning process. Also, BioMatrix Technology automatically adjusts to the biovariability of different patients to prevent undesirable variations in the scanning process. As a result, BioMatrix Technology reduces examination times, cuts down on the number of repeat scans, and leads to consistent, high quality scanning results.
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH268_Siemens.jpg 800 1067 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:32Cardiovascular MRI scanner

Hologic was due to showcase the following new products at ECR 2020, which has been postponed due to the COVID-19 pandemic

, 26 August 2020/in Corona News, Product News /by 3wmedia

Breast Imaging
The 3Dimensions Mammography System is the industry’s fastest and highest resolution breast tomosynthesis system on the market. The system offers a variety of features designed to provide higher quality 3D images for radiologists, and enhanced workflow for technologists, with lowdose options, for patients. For example, the system includes Intelligent 2D imaging technology, which works with the system’s Clarity HD highresolution 3D imaging to deliver unprecedented clarity, contrast and detail at a lower dose.
Another feature available with the 3Dimensions system is the Quantra 2.2 breast density assessment software, which enables standardization in patient protocols, providing reproducible and consistent breast density assessment. Furthermore, thanks to the addition of the SmartCurve breast stabilization system, the 3Dimensions system is also clinically proven to deliver a more comfortable mammogram compared to standard compression, without compromising on speed, dose or accuracy.
Interventional
The Brevera® Breast Biopsy System with CorLumina® Imaging Technology is a real-time breast biopsy and verification system that improves the patient experience and streamlines the biopsy process from start to finish. Before the Brevera system, radiologists performing stereotactic breast biopsy procedures to diagnose breast cancer were often required to leave the patient under compression while they moved to another room to image and verify tissue samples. With the Brevera system, radiologists are able to obtain and image tissue samples in the procedure room in just a few seconds, potentially saving up to 10 minutes per patient and cutting the procedure time by up to 25%.
The Affirm® Prone Breast Biopsy System is the only dedicated prone biopsy system offering superior 2D or tomosynthesis imaging. Thanks to this high-quality 2D or tomosynthesis imaging and a field of view that’s more than 6.5 times larger than older generations of prone biopsy systems, clinicians can visualize more tissue and pinpoint subtle lesions and faint calcifications that may not be visible on older systems. Of note, more than 95% of patients reported their Affirm prone biopsy procedure was faster, more comfortable and less painful than expected. The system is designed with patients’ physical and emotional comfort in mind. Direct view of the biopsy needle is eliminated helping to reduce patient stress, and clinicians can quickly identify, target and access lesions to help reduce time spent in compression.
The Faxitron™ Core Specimen Radiography System is designed for efficiency. Within seconds this self-contained, table top unit provides highresolution imaging for immediate core sample verification in the biopsy room.
Breast Surgery
The LOCalizer™ Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. It was designed to replace the traditional wire-guided localization method, which requires placement of a wire on the day of surgery. With the tag, placement can be done weeks or months prior to surgery. For patients, this means they can arrive closer to their surgery time and experience fewer interventional procedures.
The Trident® HD Specimen Radiography System delivers enhanced image quality, improved workflow and instant sample verification during breastconserving surgeries and stereotactic breast biopsies. The Trident products are the only specimen radiographs on the market to use amorphous selenium direct capture imaging – the same detector technology used in Hologic’s 3Dimensions mammography system – to generate crisp, clear, high-resolution images.
Ultrasound
The Viera™ Portable Breast Ultrasound System is a wireless, handheld ultrasound device that delivers accurate, high-resolution diagnostic images at the point of care, enabling optimization of clinical workflow and patient pathway. The system seamlessly transmits images to smart devices and communication systems (PACS) in the office, exam room or surgical suite, and allows facilities to add interventional breast ultrasound services for a fraction of the cost of comparable cart systems. Additionally, the Supersonic Mach 30 Breast Ultrasound System provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display. The system’s enhanced ergonomics are designed to increase usability.
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/hologic_3dimensions.jpg 1700 1106 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:20Hologic was due to showcase the following new products at ECR 2020, which has been postponed due to the COVID-19 pandemic

Certified app for detecting atrial fibrillation and other arrhythmias

, 26 August 2020/in Product News /by 3wmedia

FibriCheck is a medically certified app (CE-class IIa and FDA-cleared) capable of detecting atrial fibrillation and other heart rhythm disorders, thereby preventing strokes. FibriCheck is leveraging mobile technologies for a better health. FibriCheck uses the built-in photoplethysmographic (PPG) sensors commonly found in smartphones and smartwatches to measure the rhythm of the user’s heartbeat. Employing medically-certified algorithms together with an artificially intelligent deep neural network, FibriCheck detects the presence of atrial fibrillation and other potentially fatal cardiac arrhythmias. It is as good as a 1-lead ECG and 96,5% accurate compared with a 12-lead ECG. By decentralizing the diagnostic process, FibriCheck is paving the way for broader access to effective care for individuals while reducing the total cost of healthcare for governments and insurers, thus helping to make Health 2.0 a reality for communities around the globe. FibriCheck is commercially available since May 2017, prescribed by over 1,200 doctors, used by over 110,000 people and reimbursed by selected healthcare funds.
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH265_Qompium.jpg 533 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:27Certified app for detecting atrial fibrillation and other arrhythmias

Dolphin™ (FIS) Fluid Immersion Simulation®

, 26 August 2020/in Product News /by 3wmedia

A unique, patented technology that re-distributes pressure to prevent tissue damage by emulating the effects of a body "floating" in a fluid medium. All Dolphin FIS surfaces provide an environment that promotes tissue perfusion and prevents injury related to compromised blood flow.

Dolphin FIS has been proven clinically effective at speeding the healing of advanced stage or multiple pressure ulcers, flaps, skin grafts, burns and other wound conditions and is available for beds and seat cushions, providing protection for high risk patients throughout their hospital stay or at home.

To find out more about how Dolphin can save your clinical team time and energy, while ensuring best practice, reduced risk and costs, visit www.dolphinfis.com. Alternatively, please contact Joerns Healthcare on +44 1905 842 211 or send an email to export@joerns.com. Distributor enquiries welcome.
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/Joerns_Dolphin.jpg 1639 2362 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:35Dolphin™ (FIS) Fluid Immersion Simulation®

Handheld respiratory pressure meter

, 26 August 2020/in Product News /by 3wmedia

The RP Check is a handheld respiratory pressure meter measuring mouth and nasal pressures (MIP, MEP and SNIP). Small, portable and lightweight the RP Check allows paediatric and adult patients to be tested with ease in various settings including bedside and Out-patient clinics as well as preoperative assessment situations. Results are instantly displayed on a large backlit display allowing multiple tests to be performed per patient. The RP Check can be used as a battery operated, standalone device, saving the last patients results on the unit. Alternatively, the RP Check can be connected to PC software for upload of results and report creation.

Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/FCP_1_Afbeelding1.jpg 534 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:22Handheld respiratory pressure meter

Excellent performance of POC HbA1c analyser demonstrated

, 26 August 2020/in Product News /by 3wmedia

EKF Diagnostics has announced the successful evaluation of its Quo-Lab® point-of-care HbA1c analyser by the European Reference Laboratory for Glycohemoglobin. In a recently published paper. The reference laboratory’s evaluation study assessed HbA1c (glycated hemoglobin) POC devices using international quality targets, posing the question ‘Are they fit for purpose?’ Out of 30 available on the market and the four that agreed to participate, only EKF’s Quo-Lab and one other analyser passed the same stringent quality criteria as laboratory analysers, achieving excellent analytical performance.
The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory Standards Institute (CLSI) protocols and how they performed when different criteria were applied using four certified IFCC and NGSP secondary reference measurement procedures (SRMPs). The reference laboratory study confirmed there was minimal bias between Quo-Lab and the mean of four SRMPs, it also passed all relevant performance criteria going far beyond what is required for NGSP and IFCC certification.
Notably, Quo-Lab showed no consistent clinically significant interference from the common hemoglobin (Hb) variants HbAS, HbAC, HbAD, HBAE and elevated A2. It also easily met imprecision criteria, achieving a ≤2.4% CV in IFCC SI units and ≤1.7% CV in DCCT units which represents a significant improvement on previous studies.
Commenting on the successful European Reference Laboratory for Glycohemoglobin evaluation, Gavin Jones, Diabetes Product Manager, EKF Diagnostics said, “The excellent performance that Quo-Lab has demonstrated in this latest study confirms that it is very definitely fit for purpose, delivering reliable HbA1c results in a range of settings. Quo-Lab® HbA1c is a desktop analyser designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use. From a simple semi-automated procedure, Quo-Lab provides test results within four minutes from a venous or finger prick blood sample of just 4 μLwww.ekfdiagnostics.com
Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/1903EKF-Quo-Lab-POC-haematology-analyser.jpg 599 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:30Excellent performance of POC HbA1c analyser demonstrated

Portable detector with embedded patient ID

, 26 August 2020/in Product News /by 3wmedia

Thales introduces the latest Pixium Portable 3543 DR, the first ever truly standalone device with embedded patient identification working in auto-detection mode without connection to any
external device. This patented product allows for images to be taken at the bedside. By simply scanning the patient’s ID bracelet the images are linked to the patient and can be stored directly on the detector. An easy-reading display indicates the number of images taken per patient and the total number of images stored in the device for an ulterior upload into the radiology room.
Ever since the launch of the Pixium Portable 3543 DR in 2016, the company has been researching on how to ensure images are seamlessly assigned to patients and easily stored in a way that allows doctors and technicians to examine multiple patients easily. By working in auto-detection mode, the new Pixium Portable 3543 DR does not need to connect to any external devices, making it easier and quicker to operate than legacy portable systems. This makes for higher efficiencies since practitioners can examine multiple patients at minimal dose, anywhere in the hospital. Thanks to its optimized workflow, errors and stress are minimized and time and money are saved. Images and patient files can be uploaded directly to the radiology room, eliminating the need for numerous CR cassettes and answering the growing need of reducing system total cost of ownership.  

Read more

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH241_Thales_new_crop.jpg 783 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:31:322021-01-08 12:10:40Portable detector with embedded patient ID
Page 74 of 83«‹7273747576›»

Latest issue of International Hospital

April 2024

24 June 2025

Sky Labs cuffless blood pressure monitor gains recognition

24 June 2025

Genomics launches predictive Health Insights test in UK

24 June 2025

HLTH Europe: Healthcare reimagined

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription